Germantown-based Correlogic Systems Inc. has long been trying to win U.S. federal approval for its OvaCheck blood test, which uses a series of algorithmic calculations to detect the presence of ovarian cancer. While the Food and Drug Administration has asked for more clinical tests of the diagnostic product, its European counterparts have given the regulatory nod for OvaCheck to be sold to physicians offices in that continent
Read more: Correlogic Systems wins European OK for OvaCheck – Washington Business Journal